24,085 Shares in Certara, Inc. (NASDAQ:CERT) Purchased by Brown Advisory Inc.

Brown Advisory Inc. acquired a new position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 24,085 shares of the company's stock, valued at approximately $238,000.

Other institutional investors have also recently modified their holdings of the company. Janney Montgomery Scott LLC purchased a new stake in Certara in the 1st quarter worth approximately $120,000. First Trust Advisors LP acquired a new position in shares of Certara during the 4th quarter valued at $140,000. Illinois Municipal Retirement Fund increased its stake in Certara by 3.9% during the 1st quarter. Illinois Municipal Retirement Fund now owns 59,721 shares of the company's stock worth $591,000 after buying an additional 2,268 shares during the period. Raymond James Financial Inc. purchased a new stake in Certara during the 4th quarter worth $3,628,000. Finally, Northern Trust Corp increased its position in shares of Certara by 14.0% in the 4th quarter. Northern Trust Corp now owns 877,010 shares of the company's stock worth $9,340,000 after purchasing an additional 108,038 shares during the last quarter. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Robert W. Baird boosted their price objective on shares of Certara from $9.00 to $13.00 and gave the company a "neutral" rating in a research report on Friday, April 11th. JMP Securities reissued a "market perform" rating on shares of Certara in a research note on Tuesday, May 6th. Morgan Stanley initiated coverage on shares of Certara in a research note on Thursday, July 3rd. They set an "equal weight" rating and a $16.00 target price for the company. Barclays upgraded shares of Certara from an "equal weight" rating to an "overweight" rating and boosted their price target for the company from $11.00 to $14.00 in a report on Thursday, May 8th. Finally, KeyCorp dropped their price target on shares of Certara from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Monday. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $15.29.

Certara Price Performance

Shares of Certara stock opened at $10.41 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.78 and a quick ratio of 2.78. Certara, Inc. has a fifty-two week low of $8.64 and a fifty-two week high of $16.93. The firm has a fifty day moving average price of $11.35 and a two-hundred day moving average price of $11.86. The company has a market cap of $1.69 billion, a PE ratio of -520.50 and a beta of 1.43.

Certara (NASDAQ:CERT - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.04. The company had revenue of $106.00 million during the quarter, compared to the consensus estimate of $104.44 million. Certara had a negative net margin of 0.67% and a positive return on equity of 5.05%. The firm's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period last year, the firm earned $0.10 EPS. Analysts expect that Certara, Inc. will post 0.28 EPS for the current year.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Want to see what other hedge funds are holding CERT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Certara, Inc. (NASDAQ:CERT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.